{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:27:12Z","timestamp":1759796832446,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ijrobp.2019.06.2505","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T11:58:19Z","timestamp":1561550299000},"page":"459-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Keeping Our Finger on the Pulse: Reaffirming the Role of Radiation Therapy in the Curative Management of Early Stage Follicular Lymphoma"],"prefix":"10.1016","volume":"105","author":[{"given":"Belinda A.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Plastaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry J.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2019.06.2505_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","article-title":"Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"89","author":"Illidge","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib2","doi-asserted-by":"crossref","first-page":"v83","DOI":"10.1093\/annonc\/mdw400","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Dreyling","year":"2016","journal-title":"Ann Oncol"},{"year":"2019","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): B-cell Lymphomas, NCCN Evidence Blocks","key":"10.1016\/j.ijrobp.2019.06.2505_bib3"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib4","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1002\/cncr.25117","article-title":"Long-term outcomes for patients with limited stage follicular lymphoma: Involved regional radiotherapy versus involved node radiotherapy","volume":"116","author":"Campbell","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib5","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0360-3016(01)01747-3","article-title":"Long-term results with radiotherapy for stage I - II follicular lymphomas","volume":"51","author":"Wilder","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ijrobp.2015.12.019","article-title":"Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study","volume":"94","author":"Ruella","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib7","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1002\/cncr.25149","article-title":"Improved survival in patients with early stage low-grade follicular lymphoma treated with radiation: A Surveillance, Epidemiology, and End Results database analysis","volume":"116","author":"Pugh","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib8","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.2008.18.1495","article-title":"Follicular lymphoma in the United States: First report of the national LymphoCare study","volume":"27","author":"Friedberg","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib9","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1002\/cncr.29491","article-title":"What is the optimal management of early-stage low-grade follicular lymphoma in the modern era?","volume":"121","author":"Vargo","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/blood-2018-04-843540","article-title":"Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: A collaborative study by ILROG","volume":"133","author":"Brady","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib11","unstructured":"Brady JL, International Lymphoma Radiation Oncology Group, 2019. Personal communication. March 27, 2019."},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijrobp.2007.09.051","article-title":"Impact of [18f] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-Hodgkin lymphoma","volume":"71","author":"Wirth","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib13","unstructured":"Lo AC, Campbell BA, Pickles T, et\u00a0al. Long-term outcomes for patients with limited stage follicular lymphoma: An update of a population-based study. Paper presented at: The American Society for Radiation Oncology 2019 Annual Meeting. September 16, 2019; Chicago, IL."},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib14","doi-asserted-by":"crossref","first-page":"e0131158","DOI":"10.1371\/journal.pone.0131158","article-title":"Radiotherapy compared to other strategies in the treatment of stage I\/II follicular lymphoma: A study of 404 patients with a median follow-up of 15 years","volume":"10","author":"Barzenje","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib15","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1200\/JCO.2018.77.9892","article-title":"Randomized trial of systemic therapy after involved-field radiotherapy in patients with early-stage follicular lymphoma: TROG 99.03","volume":"36","author":"MacManus","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib16","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.6619","article-title":"Cost-effectiveness analysis of first-line treatments for early-stage, low-grade follicular lymphoma","volume":"35","author":"Yang","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib17","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1200\/JCO.2018.79.3075","article-title":"Early-stage follicular lymphoma: What is the preferred treatment strategy?","volume":"36","author":"Yang","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib18","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","article-title":"Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: An open-label, multicentre, randomised, phase 3 non-inferiority trial","volume":"381","author":"Rummel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib19","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1097\/HS9.0000000000000160","article-title":"Rituximab with involved field irradiation for early-stage nodal follicular lymphoma: Results of the MIR study","volume":"2","author":"Herfarth","year":"2018","journal-title":"HemaSphere"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib20","unstructured":"Dabaja B, MD Anderson Cancer Centre, 2019. Personal communication. May 15, 2019."},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib21","unstructured":"MacManus MP, Trans-Tasman Radiation Oncology Group, 2019. Personal communication. April 11, 2019."},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11864-014-0286-4","article-title":"Radiotherapy of follicular lymphoma: Updated role and new rules","volume":"15","author":"Yahalom","year":"2014","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/CCO.0b013e328356898b","article-title":"Early stage follicular lymphoma, current management and controversies","volume":"24","author":"Jacobson","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib24","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1182\/blood-2018-99-114097","article-title":"Outcomes of stage I and II follicular lymphoma in the era of 18F-FDG PET-CT staging: An international collaborative study from the Australian lymphoma alliance","volume":"132","author":"Tobin","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2019.06.2505_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2407-11-87","article-title":"Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter phase II trial-MIR trial","volume":"11","author":"Witzens-Harig","year":"2011","journal-title":"BMC Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619333930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619333930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:45:04Z","timestamp":1759743904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301619333930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0360301619333930"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.06.2505","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Keeping Our Finger on the Pulse: Reaffirming the Role of Radiation Therapy in the Curative Management of Early Stage Follicular Lymphoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.06.2505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}